Low Folate and the Risk of Cognitive and Functional Deficits in the Very Old: The Monzino 80-plus Study

Journal of the American College of Nutrition

Volumn 25, Issue 6, 2006, Pages 502-508

  Tettamanti, Mauro ^a   Garrì, Maria Teresa ^a   Nobili, Alessandro ^a   Riva, Emma ^a   Lucca, Ugo ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Cognitive deficits; Dementia; Elderly; Folate; Functional disability; Vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID;

AGED; AGING; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; COVARIANCE; DAILY LIFE ACTIVITY; DEMENTIA; DIETARY INTAKE; FEMALE; FOLIC ACID DEFICIENCY; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HEALTH SURVEY; HUMAN; INSTRUMENTAL ACTIVITIES OF DAILY LIVING; ITALY; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; RISK ASSESSMENT; SPONTANEOUS BEHAVIOR INTERVIEW BASIC ACTIVITIES OF DAILY LIVING; VITAMIN BLOOD LEVEL;

ACTIVITIES OF DAILY LIVING; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; GERIATRIC ASSESSMENT; HUMANS; LINEAR MODELS; MALE; NUTRITIONAL REQUIREMENTS; VITAMIN B 12; VITAMIN B COMPLEX;

EID: 33846612334     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2006.10719565     Document Type: Article

References (60)

1. Lucca U, Tediosi F, Tettamanti M: –Dimensione epidemiologica e impatto economico delle demenze in Italia— (in Italian) [–Epidemiologic dimension and economic impact of dementia in Italy—]. Milano: Emme Edizioni, 2001.
2. Hebert LE, Scherr PA, Bienias JL, Bennett DA, Evans DA: Alzheimer disease in the US population. Prevalence estimates using the 2000 census. Arch Neurol 60: 1119-1122, 2003.
3. Martin GM: Frontiers of aging. Science 294: 13, 2001.
4. Schoenmaker N, Van Gool WA: The age gap between patients in clinical studies and in the general population: a pitfall for dementia research. Lancet Neurol 3: 627-630, 2004.
5. Selhub J, Bagley LC, Miller J, Rosenberg IH: B vitamins, homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr 71(Suppl): 614S-620S, 2000.
6. Strachan RW, Henderson JG: Psychiatric syndromes due to avitaminosis B12 with normal blood and bone marrow. Q J Med 34: 303-317, 1965.
7. Strachan RW, Henderson JG: Dementia and folate deficiency. Q J Med 36: 189-204, 1967.
8. Goodwin JS, Goodwin JM, Garry PJ: Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 249: 2917-2921, 1983.
9. La Rue A, Koehler KM, Wayne SJ, Chiulli SJ, Haaland KY, Garry PJ: Nutritional status and cognitive functioning in a normally aging sample: a 6-y reassessment. Am J Clin Nutr 65: 20-29, 1997.
10. Duthie SJ, Whalley LJ, Collins AR, Leaper S, Berger K, Deary IJ: Homocysteine, B vitamin status, and cognitive function in the elderly. Am J Clin Nutr 75: 908-913, 2002.
11. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U: Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer's disease and vascular dementia. Am J Clin Nutr 80: 114-122, 2004.
12. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Tettamanti M, Lucca U: Homocysteine and B vitamins in mild cognitive impairment and dementia. Clin Chem Lab Med 43: 1096-1100, 2005.
13. Ebly EM, Schaefer JP, Campbell NRC, Hogan DB: Folate status, vascular disease and cognition in elderly Canadians. Age Ageing 27: 485-491, 1998.
14. Snowdon DA, Tully CL, Smith CD, Perez Riley K, Markesbery WR: Serum folate and severity of atrophy of the neocortex in Alzheimer's disease: findings from the Nun Study. Am J Clin Nutr 71: 993-998, 2000.
15. Botez MI, Fontaine F, Botez T, Bachevalier J: Folate-responsive neurological and mental disorders: report of 16 cases. Neuropsychological correlates of computerized transaxial tomography and radionuclide cisternography in folic acid deficiencies. Eur Neurol 16: 230-246, 1997.
16. Clarke R, Smith D, Jobst KA, Refsum H, Sutton L, Ueland PM: Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55: 1449-1455, 1998.
17. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C, and the CERAD investigators: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39: 1159-1165, 1989.
18. Folstein MF, Folstein SE, McHugh PR: –Mini-Mental State—. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189-198, 1975.
19. Lawton MP, Brody EM: Assessment of older people: Self-Maintaining and Instrumental Activities of Daily Living. Gerontologist 9: 179-186, 1969.
20. Lucca U, Tettamanti M, Martelli P, Lucchelli F, Alberoni M, Spagnoli A: Spontaneous Behaviour Interview: from test performance to daily life-based Alzheimer patient evaluation (Abstract). –The Challenge of Dementias.— Edinburgh, UK: The Lancet, p 58, 1996.
21. D'Ath P, Katona P, Mullan E, Evans S, Katona C: Screening, detection and management of depression in elderly primary care attenders. I: the acceptability and performance of the 15 item Geriatric Depression Scale (GDS15) and the development of short versions. Fam Pract 11: 260-266, 1994.
22. –Diagnostic and Statistical Manual of Mental Disorders,— 4th ed. DSM-IV. Washington, DC: American Psychiatric Association, 1994.
23. Thal LJ, Grundman M, Golden R: Alzheimer's disease: A correlational analysis of the Blessed Information-Memory-Concentration Test and the Mini-Mental State Exam. Neurology 36: 262-264, 1986.
24. Solomon PR, Adams FA, Groccia ME, DeVeaux R, Growdon JH, Pendlebury WW: Correlational analysis of five commonly used measures of mental status/functional abilities in patients with Alzheimer disease. Alzheimer Dis Assoc Disord 13: 147-150, 1999.
25. Blessed G, Tomlinson BE, Roth M: The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Brit J Psychiat 114: 797-811, 1968.
26. Kado DM, Karlamangla AS, Huang M-H, Troen A, Rowe JW, Selhub J, Seeman TE: Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med 118: 161-167, 2005.
27. Bottiglieri T, Reynolds EH, Laundy M: Folate in CSF and age (letter). J Neurol Neurosurg Psychiatry 69: 562, 2000.
28. Serot JM, Christmann D, Dubost T, Béné MC, Faure GC: CSFfolate concentrations are decreased in late-onset Alzheimer's patients. J Neurol Transm 108: 93-99, 2001.
29. Crystal HA, Ortof E, Frishman WH, Gruber A, Hershman D, Aronson M: Serum vitamin B12 concentrations and incidence of dementia in a healthy elderly population: a report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 42: 933-936, 1994.
30. Basun H, Fratiglioni L, Winbland B: Cobalamin concentrations are not reduced in Alzheimer's disease: results from a populationbased study. J Am Geriatr Soc 42: 132-136, 1994.
31. Wang H-X, Wahlin Å, Basun H, Fastbom J, Winbland B, Fratiglioni L: Vitamin B12 and folate in relation to the development of Alzheimer's disease. Neurology 56: 1188-1194, 2001.
32. Wahlin Å, Hill RD, Winbland B, Bäckman L: Effects of serum vitamin B12 and folate status on episodic memory performance in very old age: A population-based study. Psychol Aging 11: 487-496, 1996.
33. Lindeman RD, Romero LJ, Koehler KM, Liang HC, LaRue A, Baumgartner RN, Garry PJ: Serum vitamin B12, C and folate concentrations in the New Mexico Elder Survey: correlations with cognitive and affective functions. J Am Coll Nutr 19: 68-76, 2000.
34. Allen RH, Stabler SP, Savage DG, Lindenbaum J: Diagnosis of cobalamin deficiency: I. Usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 34: 90-98, 1990.
35. Savage DG, Lindenbaum J, Stabler SP, Allen RH: Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiency. Am J Med 96: 239-246, 1994.
36. Green R, Kinsella LJ: Cobalamin deficiency (reply to a letter). Neurology 47: 310-311, 1996.
37. Chanarin I, Metz J: Diagnosis of cobalamin deficiency: the old and the new. Br J Haematol 97: 695-700, 1997.
38. Carmel R: Current concepts in cobalamin deficiency. Annu Rev Med 51: 357-375, 2000.
39. Solomon LR: Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood 105: 978-985, 2005.
40. Stabler SP, Allen RH, Savage DG, Lindenbaum J: Clinical spectrum of cobalamin deficiency. Blood 76: 871-881, 1990.
41. Lindenbaum J, Rosenberg IH, Wilson PWF, Stabler SP, Allen RH: Prevalence of cobalamin deficiency in the Framingham elderly population. Am J Clin Nutr 60: 2-11, 1994.
42. Metz J, Bell AH, Flicker L, Bottiglieri T, Ibrahim J, Seal E, Schultz D, Savoia H, McGrath KM: The significance of subnormal serum vitamin B12 concentration in older people: A case control study. J Am Geriatr Soc 44: 1355-1361, 1996.
43. Carmel R, Green R, Jacobsen DW, Rasmussen K, Florea M, Azen C: Serum cobalamin, homocysteine, and methylmalonic acid concentrations in a multiethnic population: ethnic and sex differences in cobalamin and metabolite abnormalities. Am J Clin Nutr 70: 904-910, 1999.
44. Morris MS, Jacques PF, Rosenberg IH, Selhub J: Elevated serum methylmalonic acid concentrations are common among elderly Americans. J Nutr 132: 2799-2803, 2002.
45. Lindemans J, Schoester M, van Kapel J: Application of a simple immunoadsorption assay for the measurement of saturated and unsaturated transcobalamin II and R-binders. Clin Chim Acta 132: 53-61, 1983.
46. Hvas A-M, Nexo E: Holotranscobalamin-a first choice assays for diagnosing early vitamin B12 deficiency? J Intern Med 257: 289-298, 2005.
47. Loikas S, Löppönen M, Suominen P, Møller J, Irjala K, Isoaho R, Kivelä S-L, Koskinen P, Pelliniemi T-T: RIA for serum holotranscobalamin: evaluation in the clinical laboratory and reference interval. Clin Chem 49: 455-462, 2003.
48. Lloyd-Wright Z, Hvas A-M, Møller J, Sanders TAB, Nexø E: Holotranscobalamin as an indicator of dietary vitamin B12 deficiency. Clin Chem 49: 2076-2078, 2003.
49. Refsum H, Smith AD: Low vitamin B-12 status in confirmed Alzheimer's disease as revealed by serum holotranscobalamin. J Neurol Neurosurg Psychiatry 74: 959-961, 2003.
50. McCaddon A, Blennow K, Hudson P, Hughes A, Barber J, Gray R, Davies G, Williams JHH, Duguid J, Lloyd A, Tandy S, Everall M, Cattell H, McCaddon A, Ellis D, Palmer M, Bogdanovic N, Gottfries C-G, Zetterberg H, Rymo L, Regland B: Transcobalamin polymorphism and serum holo-transcobalamin in relation to Alzheimer's disease. Dement Geriatr Cogn Disord 17: 215-221, 2004.
51. Nilsson K, Isakson A, Gustafson L, Hultberg B: Clinical utility of serum holotranscobalamin as a marker of cobalamin status in elderly patients with neuropsychiatric symptoms. Clin Chem Lab Med 42: 637-643, 2004.
52. Carmel R: Measuring and interpreting holo-transcobalamin (holotranscobalamin II). Clin Chem 48: 407-409, 2002.
53. Reynolds EH: Folic acid, ageing, depression, and dementia. BMJ 324: 1512-1515, 2002.
54. Mattson MP, Shea TB: Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26: 137-146, 2003.
55. Iskander BJ, Nelson A, Resnick D, Skene PJH, Gao P, Johnson C, Cook TD, Hariharan N: Folic acid supplementation enhances repair of the adult central nervous system. Ann Neurol 56: 221-227, 2004.
56. Bottiglieri T, Godfrey P, Flynn T, Carney MWP, Toone BK, Reynolds EH: Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine. J Neurol Neurosurg Psychiatry 53: 1096-1098, 1990.
57. Morrison LD, Smith DD, Kish SJ: Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. J Neurochem 67: 1328-1331, 1996.
58. Eto K, Asada T, Arima K, Makifuchi T, Kimura H: Brain hydrogen sulfide is severely decreased in Alzheimer's disease. Biochem Biophys Res Commun 293: 1485-1488, 2002.
59. Kruman II, Kumaravel TS, Lohani A, Pedersen WA, Cutler RG, Kruman Y, Haughey N, Lee J, Evans M, Mattson MP: Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease. J Neurosci 22: 1752-1762, 2002.
60. Doshi SN, McDowell IFW, Moat SJ, Payne N, Durrant HJ, Lewis MJ, Goodfellow J: Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation 105: 22-26, 2002.